PHARMACIE DU RING: what changed
PHARMACIE DU RING
Largest movements
- Stocks and contracts -€79,214
down €79,214 (-30.0%), from €264,276 to €185,062
- Receivables within one year +€62,796
up €62,796 (+16.2%), from €387,757 to €450,553
of which Other amounts receivable: +€49,560
- Reserves +€82,329
up €82,329 (+7.0%), from €1.2m to €1.3m
of which Distributable reserves: +€82,329
- Debts after one year -€74,785
down €74,785 (-38.9%), from €192,130 to €117,345
- Trade debts -€29,873
down €29,873 (-14.5%), from €205,315 to €175,442
- Gross operating margin +€13,686
up €13,686 (+5.3%), from €257,172 to €270,858
- Staff costs -€6,809
down €6,809 (-7.8%), from €87,728 to €80,919
- Taxes +€6,184
up €6,184 (+19.2%), from €32,170 to €38,353
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,693,810 | €1,665,147 | -€28,663 | -1.7% |
| Fixed assets | 21/28 | €708,882 | €691,791 | -€17,090 | -2.4% |
| Intangible fixed assets | 21 | €3,000 | €1,500 | -€1,500 | -50.0% |
| Tangible fixed assets | 22/27 | €705,882 | €690,291 | -€15,590 | -2.2% |
| Land and buildings | 22 | €690,358 | €663,462 | -€26,896 | -3.9% |
| Plant, machinery and equipment | 23 | €15,524 | €18,486 | +€2,962 | +19.1% |
| Furniture and vehicles | 24 | €0 | €8,344 | +€8,344 | |
| Current assets | 29/58 | €984,928 | €973,355 | -€11,573 | -1.2% |
| Stocks and contracts in progress | 3 | €264,276 | €185,062 | -€79,214 | -30.0% |
| Stocks | 30/36 | €264,276 | €185,062 | -€79,214 | -30.0% |
| Amounts receivable within one year | 40/41 | €387,757 | €450,553 | +€62,796 | +16.2% |
| Trade receivables | 40 | €78,251 | €91,486 | +€13,236 | +16.9% |
| Other amounts receivable | 41 | €309,506 | €359,067 | +€49,560 | +16.0% |
| Cash at bank and in hand | 54/58 | €331,590 | €337,741 | +€6,150 | +1.9% |
| Deferred charges and accrued income | 490/1 | €1,305 | €0 | -€1,305 | -100% |
| Total equity and liabilities | 10/49 | €1,693,810 | €1,665,147 | -€28,663 | -1.7% |
| Equity | 10/15 | €1,186,909 | €1,269,238 | +€82,329 | +6.9% |
| Contributions | 10/11 | €6,200 | €6,200 | = | 0.0% |
| Reserves | 13 | €1,180,709 | €1,263,038 | +€82,329 | +7.0% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,860 | €1,860 | = | 0.0% |
| Distributable reserves | 133 | €1,178,849 | €1,261,178 | +€82,329 | +7.0% |
| Amounts payable | 17/49 | €506,901 | €395,908 | -€110,992 | -21.9% |
| Amounts payable after more than one year | 17 | €192,130 | €117,345 | -€74,785 | -38.9% |
| Financial debts | 170/4 | €192,130 | €117,345 | -€74,785 | -38.9% |
| Amounts payable within one year | 42/48 | €314,770 | €278,129 | -€36,641 | -11.6% |
| Current portion of amounts payable after more than one year | 42 | €80,563 | €80,901 | +€338 | +0.4% |
| Trade debts | 44 | €205,315 | €175,442 | -€29,873 | -14.5% |
| Suppliers | 440/4 | €205,315 | €175,442 | -€29,873 | -14.5% |
| Taxes, remuneration and social security | 45 | €23,335 | €16,278 | -€7,057 | -30.2% |
| Taxes | 450/3 | €11,101 | €11,905 | +€805 | +7.2% |
| Remuneration and social security | 454/9 | €12,234 | €4,373 | -€7,861 | -64.3% |
| Other amounts payable | 47/48 | €5,557 | €5,508 | -€49 | -0.9% |
| Accrued charges and deferred income | 492/3 | - | €434 | +€434 | |
| Remuneration, social security and pensions | 62 | €87,728 | €80,919 | -€6,809 | -7.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €55,424 | €56,768 | +€1,344 | +2.4% |
| Other operating charges | 640/8 | €2,083 | €2,909 | +€827 | +39.7% |
| Gross operating margin | 9900 | €257,172 | €270,858 | +€13,686 | +5.3% |
| Operating profit (loss) | 9901 | €111,937 | €130,262 | +€18,325 | +16.4% |
| Financial income | 75/76B | €1,863 | €876 | -€988 | -53.0% |
| Recurring financial income | 75 | €1,863 | €876 | -€988 | -53.0% |
| Financial charges | 65/66B | €12,728 | €10,455 | -€2,274 | -17.9% |
| Recurring financial charges | 65 | €12,728 | €10,455 | -€2,274 | -17.9% |
| Profit (loss) for the period before taxes | 9903 | €101,071 | €120,683 | +€19,611 | +19.4% |
| Income taxes | 67/77 | €32,170 | €38,353 | +€6,184 | +19.2% |
| Profit (loss) for the period | 9904 | €68,902 | €82,329 | +€13,428 | +19.5% |
| Profit (loss) for the period to be appropriated | 9905 | €68,902 | €82,329 | +€13,428 | +19.5% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 March 2024 and 31 March 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 3 November 2026 via checked.be.